≡ Erbitux - Enhanced Efficacy Demonstrated In Patients With KRAS Wild-Type Tumors In First Line Metastatic Colorectal Cancer
The valuable effect of adding up Erbitux to average chemotherapy contained by the overall population be demonstrated in the CRYSTAL and OPUS trial, and presented at finishing year’s ASCO round-table.3,4 Since subsequent, several minor study personal indicate that the KRAS esteem of a patient’s tumor have an impact at the line-up of the […]
